1.- MC. QUILLAN G.M. ALTER MJ, MOYER LA
et al A population based serologic study of hepatitis C virus infection in the United
States. In Rizzetto M; Purcell RH, Gerin J. L., Vernme ed. Viral Hepatitis in liver
Disease Turin: Edicioni Minerva Medic, 1997; 267-270.
2.- LAU T.Y.D, KIENER D.R, GHANY M.G,
PARK Y et al. 10-Year follow-up after interferon- Therapy for chronic hepatitis C.
Hapatology 1998; 28:1121-1127.
3.- NIEDERAU C, LANGE S, HEINTGES T,
ERHARDT A et al. Prognosis of Chronic Hepatitis C : Results of a large, prospective cohort
study. Hepatology 1998; 28: 1687-1695.
4.- HOOFNAGLE J.H, D IBISCEGLIE A M The
Treatment of Chronic viral hepatitis N Engl J Med 1997; 336: 347-56.
5.- LIND SAY K.L. Therapy of hepatitis C
: Overview. Hepatology 1997;26 : 715-775.
6.- BRACONIER J.H. PAULSEN O, ENGMAN K,
WIDELL A. Combined alpha.interferon and ribavirin treatment in chronic hepatitis C: a
pilot study. Scand J infect Dis 1995; 27: 325-9.
7.- LAUMY, KAO JH, YANG PM, WANG J, et
al. Long-term efficacy of ribavirin plus interferon alpha in the treatment of chronic
hepatitis C. Gastroenterology 1996;111:1307-12.
8.- CAMPS J, CRISOTOMOS G, GARCIA-GRANERO
M et al Prediction of the response chronic hepatitis C to interferon alpha: a statistical
analysis of pre-treatment variables. Gut 1993; 34: 1714-7
9.- TSUBOTA A, CHAYAMA A, IKEDA K et al.
Factors predictive of response to interferon alpha therapy in hepatitis C infection
Hepatology 1995; 19: 1028-94
10.- CAMMAC C, CRAXM A, TINE F et al
Predictors of response to alpha interferon in chonic hepatitis c: a multivariatete
analysis on 361 treated patients (abstract) hepatology 1992; 16: 131-A.
11.- GARCIA- MONZON C. JARA P,
FERNANDEZ-BERMEJO M et al. Chonic Hepatitis C in Children : A Clinical and Inmuno
histochemical comparative study with adult patients. Hepatology 1998; 28: 1696-1701
12.- ANONYMOUS. National Institutes of
Health Consensus Development Conference Panel Statement: management : of Hepatitis C.
Hepatology 1997; 26: 2S-10 S
13.- DHUMEAUX D, DOFFUEL M, GALMICHE J.
P. A. French consensus conference on hepatitis C : Screening and treatment . J hepatotol
1997; 27: 941-4.
14.- ORITO E, MIZOKAMI M; SUZUKI K, et al
Loss of serum HCV-RNA at week 4 of interferon alpha therapy in associated with more
favaurable long-term response in patients with chronic hepatritis C. J Med. virol 1995;
46: 109-15.
15.- AMPURDANES S, OLMEDO E, MALUENDA M D
et al. Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded
by rapid clearence of HVC-RNA from serum J. Hepatol. 1996, 25:827-32.
16.- KARINO Y, TOYOTA J, SUGAMARA M et
al. Early loss of serum hepatitis C. Virus RNA can predict a sustained response to
interferon therapy in patients with chronic hepatitis C. Am. J. Gastroenterol 1997; 92:
61-5
17.- BROUWER J.T; NEVENS F, KLETER B, et
al Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux
study in 336 patients. J. Hepatology 1998; 28: 951-959
18.- BELLOBUONO A, MONDAZZI L, TEMPINI S
et al . Should patients with early loss of serum HCV-RNA during alpha interferon theraphy
for chronic hepatitis C be treated for 6 or 12 months ? J Hepatology 1999; 30:8-13.
19.- BROUWER JT, HANSEN B.E, NIESTERS
H.G.M. et al Early predictión of response in interferon monotherapy and in interferon
–ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 week versus ALT.
J. Hepatology 1999; 30: 192-198.
